Clinical Trials Sponsored by Hebei Provincial Cancer Hospital

Total 574 results

Hebei Provincial Hospital of Traditional Chinese...

Not yet recruiting

A New Delineation Approach for Oral Cavity, Oropharynx, Larynx and Hypopharynx in IMRT for Head and Neck Cancer

Head and Neck Cancer

China
Hubei Cancer Hospital

Recruiting

Neoadjuvant Radiotherapy and Immediate Implant-Based Breast Reconstruction

Breast Cancer | Implant Breast Reconstruction | Neoadjuvant Radiotherapy

China
Hubei Cancer Hospital

Recruiting

Pifenidone Prophylactic Therapy for Radiation Lung Injury in Patients Who Have Previously Received Immune Checkpoint Inhibitors

Lung Cancer

China
Hubei Cancer Hospital

Enrolling by invitation

Investigating the Effects of Different Incision Types on Aesthetic Outcomes and Incision-related Complications After Breast Reconstruction Surgery

Breast Neoplasm Female

China
Hubei Cancer Hospital

Completed

Chemoradiotherapy for Patients With Locally Advanced Nasopharyngeal Carcinoma Using Raltitrexed-Cisplatin

Nasopharyngeal Carcinoma

China
Hubei Cancer Hospital

Enrolling by invitation

Apatinib Combined With Radiotherapy in Patient With BM From Drive Gene Negative NSCLC

NSCLC

China
Hubei Cancer Hospital

Recruiting

Omitting CTV for Locally Advanced NSCLC Responded to Immunotherapy and Chemotherapy

Non Small Cell Lung Cancer | Radiotherapy | Immunotherapy | Locally Advanced

China
Hubei Cancer Hospital

Recruiting

Selected De-escalation Radiotherapy for Postoperative Head and Neck Squamous Cell Carcinoma (iCSDeR)

Surgery | Head and Neck Squamous Cell Carcinoma | Radiotherapy | Immunotherapy

China
Hubei Cancer Hospital

Recruiting

Impact of Baduanjin Qigong Exercise on Fatigue in Patients With NSCLC Undergoing Adjuvant Chemotherapy

Fatigue

China
Hubei Cancer Hospital

Recruiting

Toripalimab Combined With Anlotinib and SBRT in Patients With Untreated Brain Metastases of Driven Gene-negative NSCLC

NSCLC

China
Hubei Cancer Hospital

Recruiting

Ondanstron Weekly vs Every 3 Weeks for Prevention of Nausea and Vomiting Induced by Chemotherapy Combined With PD-1 Blockade

Nausea With Vomiting Chemotherapy-Induced

China
Hubei Cancer Hospital

Recruiting

Primary Tumor Radiotherapy Omitting CTV for Patients With Advanced NSCLC Responded to Immunotherapy and Chemotherapy

Radiotherapy | Immunotherapy | Advanced Non-Small Cell Squamous Lung Cancer

China
Hubei Cancer Hospital

Recruiting

Single-drug Chemotherapy Plus Immunotherapy in Metastatic Non-small Cell Lung Cancer Elderly Patients

Metastatic Lung Cancer | Elderly Patients

China
Hubei Cancer Hospital

Recruiting

Surufatinib With or Wothout Immunotherapy for Advanced Colorectal Cancer in Later Line

Colorectal Neoplasms

China
Hubei Cancer Hospital

Recruiting

The Risk Factors for Acute Radiation Pneumonitis in Patients With Prior Receipt of Immune Checkpoint Inhibitors

Cancer Patients

China
Tianjin Medical University Eye Hospital
Hebei Provincial Eye Hospital; Cangzhou Eye Hospital

Recruiting

A Prospective Study of Ranibizumab in the Treatment of Postoperative Recurrent Vitreous Haemorrhage of Diabetic Retinopathy

Diabetic Retinopathy | Pars Plana Vitrectomy | Ranibizumab | Postoperative Recurrent Vitreous Hemorrhage

China
Jiangxi Provincial Cancer Hospital
Guangdong Provincial People's Hospital

Recruiting

Pathological Classification of Pulmonary Nodules in Images Using Deep Learning

Lung Cancer | Artificial Intelligence

China
Jiangxi Provincial Cancer Hospital

Recruiting

Anti-PD1 Monoclonal Antibody Combined With Nimotuzumab and Capecitabine in Patients With First-line Platinum-resistant Recurrent/Metastatic Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Jiangxi Provincial Cancer Hospital

Recruiting

The Prognostic Value of the Degree of Pathological Response of Induction Chemotherapy for NPC

Nasopharyngeal Carcinoma | Tumor Microenvironment | Pathologic Complete Response

China
Jiangxi Provincial Cancer Hospital

Recruiting

High- and Low-dose Radiotherapy Combined With Envafolimab for Metastatic Solid Tumor (ST-CR01)

Metastatic Cancer

China
Jiangxi Provincial Cancer Hospital

Recruiting

Endostar Combined With Corticosteroid for Treatment of Radiation-induced Brain Necrosis in Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Jiangxi Provincial Cancer Hospital

Not yet recruiting

Thalidomide With or Without Probiotics in Radioactive Oral Mucositis

Quality of Life | Oral Mucositis

China
Jiangxi Provincial Cancer Hospital

Completed

Clinical Efficacy of 125I Seed Implantation in the Treatment of Refractory Differentiated Thyroid Cancer

Thyroid Neoplasms
Jiangxi Provincial Cancer Hospital

Unknown

Effect of Live Combined Bifidobacterium,Lactobacillus and Enterococcus Capsules on Oral Mucositis in Nasopharyngeal Carcinoma Patients Receiving Radiotherapy.

Quality of Life | Oral Mucositis

China
Jiangxi Provincial Cancer Hospital

Recruiting

The Protection of Thyroid Function in IMRT for Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma | Hypothyroidism | Nasopharyngeal Cancer

China
Jiangxi Provincial Cancer Hospital

Recruiting

Bacterial Decolonization to Prevent Radiation-induced Oral Mucositis

Quality of Life | Nasopharyngeal Carcinoma | Bacterial Colonization | Radiation-induced Oral Mucositis

China
Jiangxi Provincial Cancer Hospital

Recruiting

A Study of Pyrotinib Plus Capecitabine Combined With SRT in HER2+ MBC With Brain Metastases

HER2-positive Metastatic Breast Cancer

China
Jiangxi Provincial Cancer Hospital

Recruiting

Oral Probiotics on Radiation Enteritis Stage Ⅱ Induced by Pelvic Concurrent Chemoradiotherapy (probiotics)

Pelvic Cancer, Enteritis, Probiotics,Chemoradiotherapy

China
Jiangxi Provincial Cancer Hospital

Recruiting

Adding PD-1 Inhibitor to Neoadjuvant and Adjuvant for NPC

Nasopharyngeal Carcinoma

China
Jiangxi Provincial Cancer Hospital

Unknown

3D Printed Bolus in Post-mastectomy Radiotherapy

Breast Neoplasms | Radiotherapy Side Effect

China
Jiangxi Provincial Cancer Hospital

Not yet recruiting

Maintenance Therapy With Toripalimab and Capecitabine Versus Capecitabine Alone in High-risk Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma | Maintenance Therapy | High-Risk Cancer
Anhui Provincial Cancer Hospital

Not yet recruiting

A Study of Envafolimab in Subjects With Stage III Non-Small Cell Lung Cancer

Non-small Cell Lung Cancer Stage III

China
Jiangxi Provincial Cancer Hospital

Recruiting

Consolidative Radiotherapy Combined With Camrelizumab and Chemotherapy for Oligometastatic Nasopharyngeal Carcinoma (NPC-CR01)

Oligometastatic Disease

China
Jiangxi Provincial Cancer Hospital

Recruiting

A Study of the Efficacy and Safety of Camrelizumab Plus Radiotherapy for Patients With Early Triple-Negative Breast

Triple-Negative Breast Cancer

China
Anhui Provincial Cancer Hospital

Completed

Avatrombopag on the Treatment of Thrombocytopenia Induced by Chemotherapy of Malignant Tumors

Thrombocytopenia

China
Zhou Fuxiang
Hubei Cancer Hospital; Henan Provincial People's Hospital; Huangshi Central Hospital...

Recruiting

Apatinib Plus Camrelizumab Combined With Docetaxel and S1 in First-line Treatment for Metastatic Gastric Cancer

Metastatic Gastric Adenocarcinoma | Metastatic Gastroesophageal Junction Adenocarcinoma

China
Peking University
Peking University Cancer Hospital & Institute; Peking University International... and other collaborators

Recruiting

Pegaspargase-COEP Chemotherapy Combined With Radiotherapy for Extra-nodal NK/T Cell Lymphoma

NK/T Cell Lymphoma Nos

China
Shen Lin
307 Hospital of PLA; Tianjin Medical University Cancer Institute and Hospital; Beijing Union Hosptial and other collaborators

Completed

Feasibility Study of SOL (S-1,Oral Leucovorin,and Oxaliplatin) for Colorectal Cancer in China (SCI-101)

Colorectal Cancer

China
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Anhui Provincial Hospital; The First People's Hospital of Hefei; Hefei Binhu...

Unknown

CAR-T Cell Immunotherapy in CD19 Positive Relapsed or Refractory Leukemia and Lymphoma

Follicular Lymphoma | Mantle Cell Lymphoma | Chronic Lymphocytic Leukemia | Acute Lymphocytic Leukemia | Diffuse Large Cell Lymphoma | B-cell Prolymphocytic Leukemia

China
Fujian Cancer Hospital
Fujian Provincial Hospital

Not yet recruiting

The Correlation Between HRD Detection and the Efficacy of PARP Inhibitors in Ovarian Cancer

Ovarian Neoplasms
The First People's Hospital of Hefei
Anhui Provincial Cancer Hospital; Simcere Pharmaceutical Co., Ltd; Anhui Jimin...

Unknown

Application of Two Anti-angiogenesis Drugs Combined With Chemotherapy in Advanced Colorectal Cancer Under the Background of Precision Medical

Colorectal Neoplasms

China
Hongmei Zheng

Recruiting

The Benefits of Continued Use of Ovarian Function Suppression After 5 Years

Endocrine Therapy | Breast Cancer Female

China
Fujian Cancer Hospital
Zhejiang Cancer Hospital; Jiangxi Provincial Cancer Hospital

Not yet recruiting

Triprilimab(JS001) and Chemotherapy Combined With Local Treatment for Multiple Metastatic NPC

Nasopharyngeal Carcinoma

China
Fujian Cancer Hospital
Zhejiang Cancer Hospital; Jiangxi Provincial Cancer Hospital

Not yet recruiting

Sufficient Chemotherapy Combine With Maintenance Chemotherapy in the Treatment of Oligometastatic Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Fujian Cancer Hospital
Zhejiang Cancer Hospital; Jiangxi Provincial Cancer Hospital

Recruiting

Radical Radiotherapy and Chemotherapy Combined With Maintenance Chemotherapy in the Treatment of Stage N3 NPC

Nasopharyngeal Carcinoma

China
Cancer Institute and Hospital, Chinese Academy...
Hubei Provincial Center for Disease Control and Prevention

Unknown

The Phase IVc of Inactivated Enterovirus 71 Vaccine (Human Diploid Cell)

Hand, Foot and Mouth Disease (HFMD)

China
Cancer Institute and Hospital, Chinese Academy...
Hubei Provincial Center for Disease Control and Prevention

Recruiting

Clinical Study of the Third Dose Immunization Schedule of COVID-19 Inactivated Vaccine, (Vero Cells) in Adults Aged 18 Years and Above (6 Months After Two Doses)

SARS-CoV-2 Infection

China
Wuhan University
Tongji Hospital; Hubei Cancer Hospital

Withdrawn

A Study of SBRT in Combination With rhGM-CSF for Stage IV NSCLC Patients Who Failed in Second-line Chemotherapy

Carcinoma, Non-Small-Cell Lung

China
Li Zhang
Hubei Cancer Hospital

Not yet recruiting

SBRT Combined With Osimertinib Compared With Osimertinib for Stage IV NSCLC

Stage IV Non-small Cell Lung Cancer

China
Xinhong Wu, PhD

Completed

Clinical Significance of Supraclavicular Lymph Node Dissection for Breast Cancer

Breast Cancer Stage III

China

Clinical Trials Sponsored by Hebei Provincial Cancer Hospital

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Benin

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations